Filing Details
- Accession Number:
- 0000884731-16-000057
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-05-13 17:59:59
- Reporting Period:
- 2016-05-12
- Filing Date:
- 2016-05-13
- Accepted Time:
- 2016-05-13 17:59:59
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
884731 | Ariad Pharmaceuticals Inc | ARIA | Biological Products, (No Disgnostic Substances) (2836) | 223106987 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1662996 | Paris Panayiotopoulos | 26 Landsdowne Street Cambridge MA 02139 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-05-12 | 26,990 | $7.41 | 88,089 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 61,099 | Direct |
Footnotes
- The reporting person purchased the shares of common stock in a private transaction with the Company pursuant to the terms of his employment agreement and a related subscription agreement, as summarized in the Current Report on Form 8-K filed by the Company on December 18, 2015. The current purchase of $200,000 worth of common stock, together with a prior purchase of $300,000 of common stock on February 1, 2016, fulfills the reporting person's agreement to purchase an aggregate of $500,000 worth of common stock from the Company at market price within the first year of his employment.